Duration: (5:54) ?Subscribe5835 2025-02-21T15:00:48+00:00
Exciting IPF Developments from 2015 ERS
(5:54)
IPF Real world long term experience with antifibrotic treatment
(7:14)
Early Diagnosis and Detection of IPF
(9:29)
Living with IPF - what is it really like?
(9:53)
What’s Next for IPF Therapy?
(11:36)
Palliative Care for Patients with IPF
(4:2)
IPF Management and Antifibrotic Therapy
(56:49)
Evaluating New Advances in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
(25:56)
What Cells in the IPF Lung are Senescent and Why Does it Matter? | Melanie Koenigshoff, MD, PhD
(18:4)
Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) | Dan Culver, DO
(15:21)
New Drugs Give Glimmer Of Hope For IPF
(1:30)
How Should We Approach GERD in ILD/IPF Now? | Harold R. Collard, MD
(21:49)
Uniting human and machine intelligence for drug discovery in IPF
(4:38)
New Approaches to the Diagnosis of IPF
(2:15)
IPF: When Work Gets Personal
(2:55)
Does DNA hold the key to understanding IPF?
(59:8)
PROFILE - IPF | Toby Maher, MD
(14:19)
Diagnosis of Idiopathic Pulmonary Fibrosis (IPF)
(14:18)
Recent Developments in Methodologies to Support the Diagnosis of IPF
Lungs\u0026You Couch Talk: Idiopathic Pulmonary Fibrosis (IPF)
(8:26)